News

Compulsory microchipping, as well as bans on ear-cropping and tail-docking, are among a set of new rules to protect cats and dogs that European lawmakers are due to vote on Thursday.
STRASBOURG, France - Compulsory microchipping, as well as bans on ear-cropping and tail-docking, are among a set of new rules ...
LONDON, GREATER LONDON, UNITED KINGDOM, June 16, 2025 /EINPresswire.com/ -- What Does The Data On The Acute Animal Microchip Implant Market Size Indicate? The animal microchip implant market size is ...
MONTREAL, May 27, 2025 /CNW/ - – Bristol Myers Squibb Canada (BMS) today announced that Health Canada has approved OPDIVO ® SC (nivolumab for subcutaneous injection) across all currently ...
All month, the shelter is offering free microchips during business hours, and no appointment is necessary. One in three pets will be reported missing in their lifetime, and microchipping is a ...
Altogether, the incidence of all major and minor device-related complications was about the same between trial participants randomized to a subcutaneous ICD or a conventional transvenous ICD and ...
Subcutaneous Opdivo showed similar efficacy and safety to intravenous Opdivo in advanced ccRCC, with a slightly higher overall response rate. The CheckMate-67T trial confirmed pharmacokinetic and ...
Lundbeck has stopped development of a subcutaneous formulation of its migraine drug Lu AG09222 as the Danish drugmaker switches its focus to intravenous delivery after seeing phase 2b data ...
Subcutaneous immunotherapy injections work the same way as their intravenous counterparts — by changing or enhancing a person’s immune responses to cancer. Immunotherapy for cancer is a broad ...
NEW YORK, March 27 (Reuters) - Merck & Co (MRK.N), opens new tab said on Thursday that it plans to launch a subcutaneously injected version of its blockbuster cancer immunotherapy Keytruda in the ...
BERLIN — Induction therapy with subcutaneous guselkumab demonstrated significant efficacy in patients with moderately to severely active ulcerative colitis (UC), according to results from the ...
The product is administered over a period of 3 to 5 minutes into the subcutaneous tissue of the abdomen or thigh by a health care provider. Opdivo Qvantig combines nivolumab, a programmed death ...